EFTRW

eFFECTOR Therapeutics, Inc. Warrant
EFTRW

Overview Fund Activity
Delisted

EFTRW was delisted on the 2nd of July, 2024.

Back to rankings

12 hedge funds and large institutions have $534K invested in eFFECTOR Therapeutics, Inc. Warrant in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
-4
Holders Change %
-25%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
3
Closed
4
Calls
$14K
Puts
–
Net Calls
+$14K
Net Calls Change
-$3K

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$25.4K

Top Sellers

1
HCM
Highbridge Capital Management
New York
-$124K
2
AC
Aristeia Capital
Connecticut
-$9.6K
3
EPM
Equitec Proprietary Markets
Illinois
-$8K
4
CL
CSS LLC
Illinois
-$7K
5
HF
HRT Financial
New York
-$4K
Name Holding Trade Value Shares
Change 		Shares
Change %
AC
1
Aristeia Capital
Connecticut
$264K -$9.6K -56,613 -4%
Goldman Sachs
2
Goldman Sachs
New York
$128K +$25.4K +125,000 +25%
WA
3
Whitebox Advisors
Minnesota
$61K – – –
MI
4
MMCAP International
Cayman Islands
$30K – – –
PA
5
Parallel Advisors
California
$13K – – –
CH
6
CVI Holdings
Delaware
$10K -$3.54K -17,596 -26%
ECM
7
Evolution Capital Management
Nevada
$10K – – –
TCM
8
Tenor Capital Management
New York
$7K – – –
ICM
9
III Capital Management
Florida
$7K – – –
JG
10
Jefferies Group
New York
$2.03K – – –
WAM
11
Wolverine Asset Management
Illinois
$2K -$951 -5,874 -32%
EPM
12
Equitec Proprietary Markets
Illinois
– -$8K -37,700 Closed
CL
13
CSS LLC
Illinois
– -$7K -28,389 Closed
HF
14
HRT Financial
New York
– -$4K -20,209 Closed
UBS Group
15
UBS Group
Switzerland
– -$1K -2,929 Closed
HCM
16
Highbridge Capital Management
New York
– -$124K – –